Editorial
The burning questions of heterotopic ossification
Annals of Translational Medicine
2015;
3
(2)
:14
(February 2015)
Research, evidence, and ethics: new technology or grey medicine
Annals of Translational Medicine
2015;
3
(2)
:15
(February 2015)
Significance of 99mTc-GSA liver scintigraphy in liver surgery and transplantation
Annals of Translational Medicine
2015;
3
(2)
:16
(February 2015)
99mTc-GSA SPECT/CT fused images for assessment of hepatic function and hepatectomy planning
Annals of Translational Medicine
2015;
3
(2)
:17
(February 2015)
Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder cancer patients?
Annals of Translational Medicine
2015;
3
(2)
:18
(February 2015)
Optimizing lung cancer screening: nodule size, volume doubling time, morphology and evaluation of other diseases
Annals of Translational Medicine
2015;
3
(2)
:19
(February 2015)
New therapies for reducing post-myocardial left ventricular remodeling
Annals of Translational Medicine
2015;
3
(2)
:20
(February 2015)
Probability of lung cancer based on the size threshold and volume-doubling time for lung nodules detected in low-dose CT screening
Annals of Translational Medicine
2015;
3
(2)
:21
(February 2015)
Original Article
Glucan supplementation enhances the immune response against an influenza challenge in mice
Annals of Translational Medicine
2015;
3
(2)
:22
(February 2015)
The role of chemokine receptor 4 and its ligand stromal cell derived factor 1 in breast cancer
Annals of Translational Medicine
2015;
3
(2)
:23
(February 2015)
Review Article
Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research
Annals of Translational Medicine
2015;
3
(2)
:24
(February 2015)
Perspective
Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?
Annals of Translational Medicine
2015;
3
(2)
:25
(February 2015)
The Voice of the Patient
Lung cancer is a global epidemic and requires a global effort
Annals of Translational Medicine
2015;
3
(2)
:26
(February 2015)
Meet the Professor1
Prof. Jacek Jassem: we should be more aggressive about tobacco control in fighting against lung cancer
Annals of Translational Medicine
2015;
3
(2)
:27
(February 2015)
News
The voice of the patient: a venue for all of our voices in Annals of Translational Medicine
Annals of Translational Medicine
2015;
3
(2)
:28
(February 2015)
Disclosure:
1. The series “Meet the Professor” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.
